Tagged: derek maetzold

July 27, 2015 @ 10:16 am By Samantha Hurst  |  

Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced it has closed the first tranche of a $20 million Series F financing, raising $11.7 million. The funding will be used to accelerate the growth in clinical adoption of Castle… Read More